Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04133701 · ClinicalTrials.gov registry record · NA
Meal Timing and Blood Pressure
A NA study of Blood Pressure and Neurovascular Control, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT04133701: Completed NA study of Blood Pressure and Neurovascular Control, sponsored by University of Wisconsin, Madison.
NCT04133701 is a NA study of Blood Pressure and Neurovascular Control that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 34 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04133701, a NA study of Blood Pressure and Neurovascular Control, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
Brain blood flow, blood pressure, and neurovascular control mechanisms will be measured in middle-aged adults before and after a brief intervention period. The intervention will consist of changing the time in which the participant consumes food each day.
Primary Outcome
Utilize an ambulatory blood pressure monitor to measure blood pressure values continuously over a 24-hour period.
Conditions Studied
Interventions
- BEHAVIORAL Time-Restricted Feeding
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2022-12-16 |
| Phase | NA |
What the finished NCT04133701 record still lists
NCT04133701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Time-Restricted Feeding is the first listed.
NCT04133701 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04133701 about?
NCT04133701 is a clinical study titled "Meal Timing and Blood Pressure". Brain blood flow, blood pressure, and neurovascular control mechanisms will be measured in middle-aged adults before and after a brief intervention period. The intervention will consist of changing the time in which the participant consumes food each day.
What is the current status of trial NCT04133701?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-02-02. Estimated completion is 2022-12-16.
What conditions does trial NCT04133701 study?
This clinical trial studies the following conditions: Blood Pressure, Neurovascular Control.
What interventions are being tested in trial NCT04133701?
The interventions under investigation include: Time-Restricted Feeding (BEHAVIORAL).
Who is sponsoring clinical trial NCT04133701?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04133701 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04133701's enrollment target sits among peer trials
34 74th of 101 higher than 28 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI